Lymphoma Hub (@lymphomahub) 's Twitter Profile
Lymphoma Hub

@lymphomahub

A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia. linktr.ee/LymphomaHub_ #lymsm

ID: 1582593798

linkhttp://www.lymphomahub.com calendar_today10-07-2013 08:56:22

10,10K Tweet

10,10K Takipçi

2,2K Takip Edilen

Lymphoma Hub (@lymphomahub) 's Twitter Profile Photo

CONGRESS | #18ICML | PRESENTATION Christopher Fox Chris Fox Uni of Nottingham #WeAreUoN presents results from Cohort 1 of the phase II PRiZM+ study assessing the safety and efficacy of the zanubrutinib monotherapy in patients with R/R PCNSL (N = 20). The ORR at 8 weeks was 50%, with a

CONGRESS | #18ICML | PRESENTATION
Christopher Fox <a href="/ProfChrisPFox/">Chris Fox</a> <a href="/UniofNottingham/">Uni of Nottingham #WeAreUoN</a> presents results from Cohort 1 of the phase II PRiZM+ study assessing the safety and efficacy of the zanubrutinib monotherapy in patients with R/R PCNSL (N = 20).
The ORR at 8 weeks was 50%, with a